Answers are grounded in this paper and cite their sources.
Introduction Low-grade foetal adenocarcinoma (L-FLAC) of the lung is an exceptionally rare neoplasm, accounting for 0.1-0.5% of pulmonary adenocarcinomas. It is recognized by the World Health Organization as a distinct subtype with characteristic histological and molecular features. Recognition is essential, as L-FLAC typically affects younger, non-smoking women and carries a favourable prognosis with complete surgical resection. Case Report A 44-year-old woman with no past medical history presented with a six-month history of non-productive cough and no systemic symptoms. She was a never-smoker, and physical examination was unremarkable. Computed Tomography (CT) of the thorax demonstrated a large left lower lobe mass obstructing the origin of the left lower lobe bronchus. Fluorodeoxyglucose (FDG) positron emission tomography (PET) showed a lobulated, intensely avid mass extending to the left hilum without nodal or distant metastasis. Bronchoscopy revealed complete occlusion of the left lower lobe bronchus, but biopsies were non-diagnostic. A CT-guided biopsy demonstrated adenocarcinoma with enteric differentiation and thyroid transcription factor-1 (TTF-1) positivity. Testing for ALK and ROS1 rearrangements was negative, and staging was pT4N0M0. The patient underwent a left pneumonectomy. Histology showed adenocarcinoma with cribriform, papillary, and solid architecture composed of cells with uniform nuclei, cytoplasmic vacuolation, and scattered morules. Immunohistochemistry demonstrated diffuse nuclear and cytoplasmic β-catenin expression, confirming low-grade foetal adenocarcinoma of the lung. Discussion Low-grade foetal adenocarcinoma resembles the pseudoglandular stage of foetal lung development and demonstrates nuclear β-catenin staining with morule formation. Unlike the high-grade variant, L-FLAC is usually localized, lacks common oncogenic driver mutations, and is associated with excellent long-term outcomes following complete resection. Necrosis, although less commonly described, may occur without indicating aggressive behaviour. The five-year survival rate exceeds 75%. This case emphasizes the importance of recognizing L-FLAC as a distinct pathological entity, as accurate diagnosis influences surgical planning, prognostic counselling, and contributes to the limited published experience with this rare tumour.
No takes yet. Share an insight, caveat, or question.
AL-Fori et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: